These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19265689)

  • 21. Bisphosphonate therapy and dental treatment.
    Phillips G
    J Mich Dent Assoc; 2009 Aug; 91(8):40, 42-5. PubMed ID: 19722373
    [No Abstract]   [Full Text] [Related]  

  • 22. Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: a retrospective study.
    Ibrahim T; Barbanti F; Giorgio-Marrano G; Mercatali L; Ronconi S; Vicini C; Amadori D
    Oncologist; 2008 Mar; 13(3):330-6. PubMed ID: 18378544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Osteonecrosis of the jaw associated with the use of bisphosphonates in multiple myeloma: report of four cases and literature review].
    Li LH; Wu XB; Chen WM; Chen JX; Wu Y; Chen SL
    Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2986-7. PubMed ID: 19080077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonate-associated osteonecrosis can hide jaw metastases.
    Bedogni A; Saia G; Ragazzo M; Bettini G; Capelli P; D'Alessandro E; Nocini PF; Lo Russo L; Lo Muzio L; Blandamura S
    Bone; 2007 Dec; 41(6):942-5. PubMed ID: 17905677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy.
    Favia G; Pilolli GP; Maiorano E
    Bone; 2009 Sep; 45(3):406-13. PubMed ID: 19450715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: a Belgian case series.
    Saussez S; Javadian R; Hupin C; Magremanne M; Chantrain G; Loeb I; Decaestecker C
    Laryngoscope; 2009 Feb; 119(2):323-9. PubMed ID: 19172621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Osteonecrosis of the jaw following complex tumour treatment using bisphosphonates].
    Machálka M
    Vnitr Lek; 2006 Nov; 52 Suppl 2():79, 81-2. PubMed ID: 18181284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment.
    Fehm T; Felsenberg D; Krimmel M; Solomayer E; Wallwiener D; Hadjii P
    Breast; 2009 Aug; 18(4):213-7. PubMed ID: 19651512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinguishing features of the oral cavity and its predisposition to osteonecrosis.
    McCauley LK; Li X
    J Musculoskelet Neuronal Interact; 2007; 7(4):356-7. PubMed ID: 18094511
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
    Dodson TB
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteonecrosis of the jaw and the role of bisphosphonates: a critical review.
    Silverman SL; Landesberg R
    Am J Med; 2009 Feb; 122(2 Suppl):S33-45. PubMed ID: 19187811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphosphonates and dental implants: current problems.
    Flichy-Fernández AJ; Balaguer-Martínez J; Peñarrocha-Diago M; Bagán JV
    Med Oral Patol Oral Cir Bucal; 2009 Jul; 14(7):E355-60. PubMed ID: 19561566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.
    Allen MR; Burr DB
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):61-70. PubMed ID: 19371816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive review of bisphosphonate therapy: implications for the oral and maxillofacial surgery patient.
    Ruggiero SL; Carlson ER; Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):1. PubMed ID: 19371808
    [No Abstract]   [Full Text] [Related]  

  • 35. Bisphosphonates--what the dentist needs to know: practical considerations.
    Fantasia JE
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):53-60. PubMed ID: 19371815
    [No Abstract]   [Full Text] [Related]  

  • 36. Osteonecrosis of the jaw: an update and review of recommendations.
    Novince CM; Ward BB; McCauley LK
    Cells Tissues Organs; 2009; 189(1-4):275-83. PubMed ID: 18765930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis.
    Tubiana-Hulin M; Spielmann M; Roux C; Campone M; Zelek L; Gligorov J; Samson J; Lesclous P; Laredo JD; Namer M
    Crit Rev Oncol Hematol; 2009 Jul; 71(1):12-21. PubMed ID: 19070505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?
    Mawardi H; Treister N; Richardson P; Anderson K; Munshi N; Faiella RA; Woo SB
    J Oral Maxillofac Surg; 2009 Mar; 67(3):593-601. PubMed ID: 19231786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comment on the article "Bisphosphonate-associated osteonecrosis of the jaw in rheumatology: a systematic review" by Capsoni Franco].
    Bertoldo F; Bianchi G
    Reumatismo; 2008; 60(3):234-5; author reply 236. PubMed ID: 19004122
    [No Abstract]   [Full Text] [Related]  

  • 40. Histopathologic findings in bone from edentulous alveolar ridges: a role in osteonecrosis of the jaws?
    Kassolis JD; Scheper M; Jham B; Reynolds MA
    Bone; 2010 Jul; 47(1):127-30. PubMed ID: 20399289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.